Edition:
United States

Oncopeptides AB (ONCO.ST)

ONCO.ST on Stockholm Stock Exchange

133.00SEK
6:43am EDT
Change (% chg)

-4.80kr (-3.48%)
Prev Close
137.80kr
Open
136.80kr
Day's High
137.00kr
Day's Low
132.60kr
Volume
43,927
Avg. Vol
138,418
52-wk High
209.00kr
52-wk Low
60.25kr

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Per Wold-Olsen

70 2018 Chairman of the Board

Jakob Lindberg

45 2011 Chief Executive Officer

Birgitta Stahl

47 2016 Chief Financial Officer

Christian Jacques

2018 Executive Vice President Clinical Strategy and Chief Scientific Officer

Eva Nordstrom

47 2012 Vice President, Head of Clinical Development